Prediction and evaluation of protein farnesyltransferase inhibition by commercial drugs

Amanda J. Degraw, Michael J. Keiser, Joshua D. Ochocki, Brian K. Shoichet, Mark D. Distefano

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Abstract

The similarity ensemble approach (SEA) relates proteins based on the set-wise chemical similarity among their ligands. It can be used to rapidly search large compound databases and to build cross-target similarity maps. The emerging maps relate targets in ways that reveal relationships one might not recognize based on sequence or structural similarities alone. SEA has previously revealed cross talk between drugs acting primarily on G-protein coupled receptors (GPCRs). Here we used SEA to look for potential off-target inhibition of the enzyme protein farnesyltransferase (PFTase) by commercially available drugs. The inhibition of PFTase has profound consequences for oncogenesis, as well as a number of other diseases. In the present study, two commercial drugs, Loratadine and Miconazole, were identified as potential ligands for PFTase and subsequently confirmed as such experimentally. These results point toward the applicability of SEA for the prediction of not only GPCR-GPCR drug cross talk but also GPCR-enzyme and enzyme-enzyme drug cross talk.

Original languageEnglish (US)
Pages (from-to)2464-2471
Number of pages8
JournalJournal of medicinal chemistry
Volume53
Issue number6
DOIs
StatePublished - Mar 25 2010

Fingerprint Dive into the research topics of 'Prediction and evaluation of protein farnesyltransferase inhibition by commercial drugs'. Together they form a unique fingerprint.

Cite this